In the evaluation of melanocytic lesions suspicious for melanoma, how do you decide when diagnostic ambiguity is acceptable versus when additional molecular data is necessary?

Featuring David Cotter, MD, PhD | Assistant Clinical Professor UNLV School of Medicine Las Vegas Dermatology Las Vegas, NV | Published March 06, 2026